Megestrol Acetate for the Improvement of Quality of Life in Esophageal Cancer With Chemoradiotherapy

NCT02644408 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

184

Enrollment

OTHER

Sponsor class

Conditions

Stage III Esophageal Squamous Cell Carcinoma
Stage II Esophageal Squamous Cell Carcinoma

Interventions

DRUG: Megestrol（Yining）
RADIATION: radiotherapy
OTHER: chemotherapy

Sponsor

The First Affiliated Hospital of Henan University of Science and Technology